cobas® i 601 analyzer

Description

With the cobas® Mass Spec solution, which includes the cobas® i 601 analyzer and the Ionify® reagents line, you can step away from tedious and complex manual mass spectrometry workflows and experience the simplicity and convenience of a streamlined end-to-end solution.
From sample preparation to result interpretation, Roche will be consolidating four technologies onto a single platform—ISE, clinical chemistry, immunochemistry, and mass spectrometry—maximizing efficiency and delivering enhanced medical value. Our solution is designed to enable smart testing through seamless physical and digital connectivity with other analytical units.
A broad assay menu of Ionify reagents is in development, complementing the clinical chemistry and immunoassay portfolio available on cobas pro integrated solutions. The assays include ready-for-use test kits with consistent performance and traceability to reference methods.
Enhance your lab’s capabilities by complementing existing methodologies and expanding services to new patient populations and disease areas with mass spectrometry.1-3 The cobas i 601 analyzer allows you to streamline current workflows that require dedicated and specialized staff.
Contact us to discover how mass spectrometry can seamlessly integrate into your routine laboratory, enabling broader access to this transformative technology.

Overview
The cobas® i 601 analyzer is an integrated fully automated, random-access, software controlled clinical analyzer for paramagnetic particle-based sample preparation, liquid chromatography and mass spectrometry analysis for quantitative in-vitro determinations.
The cobas® i 601 analyzer is intended to identify naturally occurring and synthetic compounds (e.g., steroids, vitamins, and others) in human specimens by ionizing the compound under investigation and the resulting ions by means of an electrical and magnetic field according to their mass-to-charge ratio.